Ionetix
San Francisco
About Ionetix
Ionetix is engaged in the development, manufacturing, and distribution of a novel class of superconducting cyclotrons for the point-of-care production of PET radioisotopes. With their significantly smaller size, lighter weight, lower power requirement, and lower price point, these systems offer significant advantages over conventional-design cyclotron technology. The company installs, operates, and manages cyclotrons producing the necessary doses of Ammonia N-13 at or near the imaging suite. Ionetix was founded in 2010 and is headquartered in
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $48.8M
- Last round: Series Unknown (Aug 2024)
- Website: ionetix.com
- Phone: (415)944-1440
Industries & Categories
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ionetix-43399 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.